Assoc. prof. Andrej Klepanec, MD, PhD.

1. 

Altaner C, Altanerova V, Cihova M, Hunakova L, Kaiserova K, Klepanec A, Vulev I, Madaric J. Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells. PLoS One. 2013 

Q1 

IF 3,534 

2. 

Madaric J, Klepanec A, Valachovicova M, Mistrik M, Bucova M, Olejarova I, Necpal R, Madaricova T, Paulis L, Vulev I. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia. Stem Cell Res Ther. 2016 

Q1 

IF 4,211 

3. 

Gershan V, Homayounieh F, Singh R, Avramova-Cholakova S, Faj D, Georgiev E, Girjoaba O, Griciene B, Gruppetta E, Hadnadjev Šimonji D, Kharuzhyk S, Klepanec A, Kostova-Lefterova D, Kulikova A, Lasic I, Milatovic A, Paulo G, Vassileva J, Kalra MK. CT protocols and radiation doses for hematuria and urinary stones: Comparing practices in 20 countries. Eur J Radiol. 2020 

Q1 

IF 3,528 

4. 

Klepanec A, Mistrik M, Altaner C, Valachovicova M, Olejarova I, Slysko R, Balazs T, Urlandova T, Hladikova D, Liska B, Tomka J, Vulev I, Madaric J. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplant. 2012 

Q1 

IF 4,422 

5. 

Klepanec A, Salat D, Harsany J, Hoferica M, Krastev G, Haring J, Mako M, Janega P, Janosikova L, Lehotska V. Neurointerventionalist and Patient Radiation Doses in Endovascular Treatment of Acute Ischemic Stroke. Cardiovasc Intervent Radiol. 2020 

Q1 

IF 2,740